A Multicenter, Randomized Study of Argatroban Versus Heparin as Adjunct to Tissue Plasminogen Activator (TPA) in Acute Myocardial Infarction: Myocardial Infarction With Novastan and TPA (MINT) Study - MINT


The goal of this study was to assess the angiographic and clinical outcomes following either argatroban or heparin-enhanced tissue plasminogen activator (TPA) among patients with ST-segment elevation myocardial infarction (MI).